Product Reports Resources Pricing Login Book a demo

Zymergen

Biotech & Life Sciences · Emeryville, United States · Founded 2013 · IPO 2021

Technology company unlocking the power of biology

Valuation $226M
Revenue $17M

Investors

23 investors on Zymergen's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 6 investors entered at this stage
Kevin Moore
Genoa Ventures
David Beyer
DCVC
Jenny Rooke
Jesse Robbins
Series B+ 11 investors entered at this stage

Global footprint

Where Zymergen has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States94.8%
🇮🇳 India3.5%
🇳🇱 Netherlands3.4%
3 countries shown

Talent graph

The shape of Zymergen's talent

Dealroom maps Zymergen's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Zymergen's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$5M patent portfolio · 36 active families

Estimated portfolio value
$5M
2.3% of market cap · 19.9× smaller than top peer Guardant Health ($105M)
36 active patent families
Where Zymergen innovates BioinformaticsBiological organismBiotechnologyDiamineGenome

Where Zymergen concentrates vs peers

Each axis is a top-10 topic across Zymergen and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Zymergen

An AI-synthesized read of the highest-engagement posts about Zymergen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zymergen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.